Summary
Nuclear DNA content was measured by static cytophotometry in smears from breast carcinomas from 80 women, and the results were correlated with other prognostic variables and survival using multivariate statistical analysis. 49% of patients had diploid tumors and 51% hyperdiploid tumors. There was a strong correlation between DNA ploidy and axillary lymph node status, tumor size, ER status, and short term survival (median follow-up 40 months). Of all parameters measured, ploidy showed the strongest correlation with survival, and was a significant prognostic indicator even when other prognostic factors were taken into account.
References
Rowley JD: Chromosomes in leukemia and lymphoma. Semin Hematol 15: 301–319, 1978
Garson OM: The value of chromosome studies in the classi-fication and management of the leukemias. Pathology 14: 291–294, 1982
Bunn PA, Whang-Peng J, Carney DN, Schlam ML, Knutsen T, Gazdar AF: DNA content analysis by flow cytometry and cytogenetic analysis in mycosis fungoides and Sezary syndrome. Diagnostic and prognostic implications. J Clin Invest 65: 1440–1448, 1980
Atkin NB: Model DNA value and chromosome number in ovarian neoplasia. A clinical and histopathologic assessment. Cancer 27: 1064–1073, 1971
Diamond LW, Bearman RM, Berry PK, Mills BJ, Nathwani BN, Weisenburger DD, Winberg CD, Teplitz RL, Rappaport H: Prolymphocytic leukemia: Flow micro-fluorimetric, immunologic and cytogenetic observations. Am J Hematol 9: 319–330, 1980
Atkin NB: Modal deoxyribonucleic acid value and survival in carcinoma of the breast. Br Med J 1: 271–272, 1972
Auer GU, Caspersson TO, Wallgren AS: DNA content and survival in mammary carcinoma. Analyt Quant Cytol 2: 161–165, 1980
Bedrossian CWM, Raber M, Barlogie B: Flow cytometry and cytomorphology in primary resectable breast cancer. Analyt Quant Cytol 3: 112–116, 1981
Friedlander ML, Hedley DW, Taylor IW: Clinical and biological significance of aneuploidy in human tumors. J Clin Pathol 37: 961–974, 1984
Sprenger E, Ulrich H, Schondorf H: The diagnostic value of cell-nuclear DNA determination in aspiration cytology of benign and malignant lesions of the breast. Analyt Quant Cytol 1: 29–36, 1979
Auer GU, Caspersson TO, Gustafsson SA, Humla SA, Ljung B-M, Nordenskjold BA, Silfversward C, Wallgren AS: Relationship between nuclear DNA distribution and estrogen receptors in human mammary carcinomas. Analyt Quant Cytol 2: 280–284, 1980
Fossa SD, Marton PF, Knudsen OS, Kaalhus O, Bormer O, Vaage S: Nuclear Feulgen DNA content and nuclear size in human breast carcinoma. Hum Pathol 13: 626–630, 1982
Fossa SD, Thorud E, Shoaib MC, Pettersen EO, Hoie J, Knudsen OS: DNA flow cytometry in primary breast carcinoma. Acta Path Microbiol Immunol Scand Sect A 92: 475–480, 1984
Auer GU, Eriksson E, Azavedo E, Caspersson T, Wallgren A: Prognostic significance of nuclear DNA content in mammary adenocarcinomas in humans. Cancer Research 44: 394–396, 1984
Cornelisse CJ, de Koning HR, Moolenaar AJ, van de Velde CJ, Ploem JS: Image and flow cytometric analysis of DNA content in breast cancer. Relation to estrogen receptor content and lymph node involvement. Analyt Quant Cytol 6: 9–18, 1984
Berryman IL, Harvey JM, Sterrett GF, Papadimitriou JM: The nuclear DNA content of human breast carcinoma: associations with clinical stage, axillary lymph node status, estrogen receptor status and outcome. Analyt Quant Cytol Histol (in press)
Kute TE, Muss HB, Anderson D, Crumb K, Miller B, Burns D, Dube LA: Relationship of steroid receptor, cell kinetics and clinical status in patients with breast cancer. Cancer Research 41: 3524–3529, 1981
Olszewski W, Darzynkiewicz Z, Rosen PP, Schwarz MK, Melamed MR: Flow cytometry of breast carcinoma: I. Relation of DNA ploidy level to histology and estrogen receptor. Cancer 48: 980–984, 1981
Olszewski W, Darzynkiewicz Z, Rosen PP, Schwarz MK, Melamed MR: Flow cytometry of breast carcinoma: II. Relation of tumor cell cycle distribution to histology and estrogen receptor. Cancer 48: 985–988, 1981
Taylor IW, Musgrove EA, Friedlander ML, Foo MS, Hedley DW: The influence of age on the DNA ploidy levels of breast tumours. Eur J Cancer Clin Oncol 19: 623–628, 1983
Raber MN, Barlogie B, Latreille J, Bedrossian C, Fritsche H, Blumenschein G: Ploidy, proliferative activity and estrogen receptor content in human breast cancer. Cytometry 3: 36–41, 1982
Moran RE, Black MM, Alpert L, Straus MJ: Correlation of cell-cycle kinetics, hormone receptors, histopathology and nodal status in human breast cancer. Cancer 54: 1586–1590, 1984
Hedley DW, Rugg CA, Ng ABP, Taylor IW: Influence of cellular DNA content on disease-free survival of stage II breast cancer patients. Cancer Research 44: 5395–5398, 1984
Ewers S-B, Langstrom E, Baldetorp B, Killander D: Flowcytometric DNA analysis in primary breast carcinomas and clinicopathological correlations. Cytometry 5: 408–419, 1984
Haag D, Goerttler K, Tschahargane C: The proliferative index (PI) of human breast cancer as obtained by flow cytometry. Path Res Pract 178: 315–322, 1984
Coulson PB, Thornthwaite JT, Woolley TW, Sugarbaker EV, Seckinger D: Prognostic indicators including DNA histogram type, receptor content and staging related to human breast cancer patient survival. Cancer Research 44: 4187–4196, 1984
Stuart-Harris R, Hedley DW, Taylor IW, Levene AL, Smith IE: Tumour ploidy, response and survival in patients receiving endocrine therapy for advanced breast cancer. Br J Cancer 51: 573–576, 1985
Horsfall DJ, Tilley WD, Orell SR, Marshall VR, Cant ELMcK: Relationship between ploidy and steroid hormone receptors in primary invasive breast cancer. Br J Cancer 53: 23–28, 1986
Hahnel R, Twaddle E: Estradiol binding by human breast carcinoma cytosols: the influence of commonly used reference parameters in the results. Eur J Cancer 14: 125–131, 1978
Berryman I, Sterrett GF, Papadimitriou JM: Feulgen DNA cytophotometry in histologic sections of mammary neoplasms. Analyt Quant Cytol 6: 19–23, 1984
Armitage P: Statistical Methods in Medical Research. Blackwell, London, 1971, pp 403–406
Kaplan EL, Meier P: Non-parametric estimation from incomplete observations. J Amer Statist Assn 53: 475–481, 1958
Buckley JD: Survival Programme. Clinical Research Unit, Walter and Eliza Hall Institute of Medical Research, Parkville, Australia, 1979
Cox DR: Regression models and life-tables. J R Statist Soc B 34: 187–202, 1972
Thomas DC: Programme ‘Risk’, Department of Epidemiology and Health, McGill University, Montreal, Quebec, 1980
Gill R: Understanding Cox's regression model.In: Baum M, Kay R, Scheurlen H (eds) Clinical Trials in Early Breast Cancer, 2nd Heidelberg Symposium. Birkhauser-Verlag, Basel, 1982
Fisher B, Redmond C, Fisher ER, Bauer M, Wolmark N, Wickerham DL, Deutsch M, Montague E, Margolese R, Foster R: Ten year results of a randomized clinical trial comparing radical mastectomy and total mastectomy with or without radiation. N Engl J Med 312: 674–681, 1985
Stal O, Klintenberg C, Franzen G, Risberg B, Arvidsson S, Bjelkenkrantz K, Skoog L, Nordenskjold B: A comparison of static cytofluorometry and flow cytometry for the estimation of ploidy and DNA replication in human breast cancer. Breast Cancer Res Treat 7: 15–22, 1986
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Harvey, J., de Klerk, N., Berryman, I. et al. Nuclear DNA content and prognosis in human breast cancer: A static cytophotometric study. Breast Cancer Res Tr 9, 101–109 (1987). https://doi.org/10.1007/BF01807362
Issue Date:
DOI: https://doi.org/10.1007/BF01807362